Stay updated on SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.

Latest updates to the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNew clarifications were added to the Publications section indicating that publications may be provided voluntarily and are auto-filled from PubMed. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the site-wide banner about government funding and operating status. The study details, eligibility criteria, and results information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedCore study data such as title, arms, outcomes, and locations appear unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedMajor update adds a government-status notice and upgrades version to v3.2.0; previous v3.1.0 reference removed.SummaryDifference1.0%

- Check70 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.